These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-004594-29 Phase II Study of VELCADETM in patients with extranodal marginal zone B-cell lymphoma of MALT-type pretreated with one prior systemic therapy regimen (X05142) 2009-10-01 due-trials
Listed as ongoing, but also has a completion date 2004-004596-11 Phase II Study of VELCADETM in patients with extranodal marginal zone B-cell lymphoma of MALT-type pretreated with more than one prior systemic therapy regimen (X05142) 2008-02-22 bad-data
Ongoing 2005-001055-38 RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT PAT... not-yet-due
Completed, but no date, and reported results 2006-005794-22 A CLINICO-PATHOLOGIC STUDY OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA bad-data
Ongoing, reported early 2006-005795-41 A CLINICO-PATHOLOGICAL PHASE II STUDY WITH TRANSLATIONAL ELEMENTS TO INVESTIGATE THE POSSIBLE INFECTIVE CAUSES OF NON-HODGKIN LYMPHOMA OF THE OCULAR ADNEXAE WITH PARTICULAR REFERENCE TO CHLAMYDIA SPE... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-011725-14 IELSG 34: A Multicenter Phase II study to evaluate the clinical activity and the safety profile of everolimus (RAD001) in marginal zone B-cell lymphomas (MZL) EudraCT Number 2009-011725-14 2013-05-01 bad-data
Other 2009-011789-26 A phase II study of R-CHOP with intensive CNS prophylaxis and scrotal irradiation in patients with primary testicular diffuse large B-cell lymphoma not-yet-due
Other 2009-012432-32 RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION vs. HIGH-D... not-yet-due
Ongoing 2011-000880-28 Bendamustine and Rituximab for the treatment of Splenic Marginal Zone Lymphoma. The IELSG-36 phase II prospective study. Bendamustina e Rituximab per il trattamento del Linfoma zona marginale sple... not-yet-due
Ongoing 2012-004896-38 A PHASE II STUDY OF CHLORAMBUCIL IN COMBINATION WITH SUBCUTANEOUS RITUXIMAB FOLLOWED BY MAINTENANCE THERAPY WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MUC... not-yet-due
Ongoing 2012-005702-22 International prospective Phase 2 trial addressing the efficacy of first-line Chlamydophila psittaci-eradicating therapy with protracted administration of doxycycline followed by eradication monitorin... not-yet-due
Ongoing 2014-003031-19 An international phase II trial assessing tolerability and efficacy of sequential Methotrexate-Aracytin-based combination and R-ICE combination, followed by high-dose chemotherapy supported by autolog... not-yet-due
Ongoing 2015-003168-35 A PHASE II TRIAL ADDRESSING FEASIBILITY AND ACTIVITY OF CLARITHROMYCIN + LENALIDOMIDE COMBINATION: A FULL ORAL TREATMENT FOR PATIENTS WITH RELAPSED/REFRACTORY MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) ... not-yet-due
Ongoing 2016-003116-12 RANDOMIZED PHASE II TRIAL ON FITNESS AND COMORBIDITY - TAILORED TREATMENT IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA (FIORELLA Trial) not-yet-due
Ongoing 2018-002364-44 MALIBU trial - Phase II study of combination ibrutinib and rituximab in untreated marginal zone lymphomas not-yet-due
Ongoing 2019-004396-38 Phase II trial of acalabrutinib in combination with tafasitamab in patients with previously treated marginal zone lymphomas (MZL) Studio di Fase II della combinazione di acalabrutinib con tafasitam... not-yet-due